The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis

[11] Fransen J(2010)Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis Ann Rheum Dis 54 686-691

[12] Helliwel PS(2006)Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 59 238-244

[13] Coates LC(2008)Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis Arthritis Rheum 157 123-128

[14] Helliwell PS(1978)Severe psoriasis–oral therapy with a new retinoid Dermatologica 11 2332-2338

[15] Coates LC(1993)The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis Clin Exp Rheumatol 42 811-818

[16] Nash P(2015)Patient’s global assessment as an outcome measure for psoriatic arthritis in clinical practice: a surrogate for measuring low disease activity? J Rheumatol 75 201-208

[17] Kvien TK(2016)Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score Ann Rheum Dis 78 1490-1495

[18] Lubrano E(2019)Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries Ann Rheum Dis 47 907-910

[19] De Socio A(2020)Residual disease activity and associated factors in psoriatic arthritis J Rheumatol 43 undefined-undefined

[20] Perrotta FM(2016)Patients with psoriatic arthritis fulfilling the minimal disease activity criteria do not have swollen and tender joints, but have active skin J Rheumatol undefined undefined-undefined

[11] Fransen J(2010)Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis Ann Rheum Dis 54 686-691

[12] Helliwel PS(2006)Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 59 238-244

[13] Coates LC(2008)Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis Arthritis Rheum 157 123-128

[14] Helliwell PS(1978)Severe psoriasis–oral therapy with a new retinoid Dermatologica 11 2332-2338

[15] Coates LC(1993)The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis Clin Exp Rheumatol 42 811-818

[16] Nash P(2015)Patient’s global assessment as an outcome measure for psoriatic arthritis in clinical practice: a surrogate for measuring low disease activity? J Rheumatol 75 201-208

[17] Kvien TK(2016)Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score Ann Rheum Dis 78 1490-1495

[18] Lubrano E(2019)Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries Ann Rheum Dis 47 907-910

[19] De Socio A(2020)Residual disease activity and associated factors in psoriatic arthritis J Rheumatol 43 undefined-undefined

[20] Perrotta FM(2016)Patients with psoriatic arthritis fulfilling the minimal disease activity criteria do not have swollen and tender joints, but have active skin J Rheumatol undefined undefined-undefined